Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1992-4-24
|
pubmed:abstractText |
Different normal and malignant human B-cell populations were studied with a twofold aim: to define which cytokines are produced in vivo, and to assess the relationship between cytokine production and kinetic state. To analyse normal B-cells representative of different stages of activation and proliferation in vivo, we purified germinal centre (GC)-B blasts and mantle B (M-B) cells from tonsils. To compare malignant B lymphocytes with their closest normal equivalent cells, we separated malignant CD5+B lymphocytes from the peripheral blood of patients with B-chronic lymphocytic leukemia (B-CLL) and normal CD5+B lymphocytes from cord blood. The expression of interleukins (IL) IL-1 alpha, IL-1 beta, tumour necrosis factor alpha (TNF-alpha), transforming growth factor beta (TGF-beta), IL-2, IL-4, and IL-6 genes was analysed using Northern and Western blotting techniques. TNF-alpha mRNA is produced by resting (M-B) and actively proliferating (GC-B) normal B lymphocytes. TGF-beta mRNA is present at high levels in resting normal M-B cells, while the transcript levels are lower in proliferating GC-B and in activated CD5+B lymphocytes. IL-2 production is limited to the actively proliferating GC-B blasts, IL-1 beta and IL-6 to resting M-B cells. The cytokine production profile of CD5+ malignant B-CLL cells differs from that of their putative normal counterparts and is more like the profile of M-B cells, since B-CLL cells produce IL-1 beta, TNF-alpha, TGF-beta, and IL-6. These observations lead to the following conclusions: among normal B lymphocyte populations, resting M-B lymphocytes are the most active cytokine producers, and B-CLL malignant B cells reflect the production pattern of normal resting B lymphocytes.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD5,
http://linkedlifedata.com/resource/pubmed/chemical/Cytokines,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-1,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-2,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-4,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-6,
http://linkedlifedata.com/resource/pubmed/chemical/Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Transforming Growth Factor beta,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0887-6924
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
6
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
120-5
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:1372670-Antigens, CD,
pubmed-meshheading:1372670-Antigens, CD5,
pubmed-meshheading:1372670-B-Lymphocytes,
pubmed-meshheading:1372670-Blotting, Northern,
pubmed-meshheading:1372670-Blotting, Western,
pubmed-meshheading:1372670-Cytokines,
pubmed-meshheading:1372670-Humans,
pubmed-meshheading:1372670-Interleukin-1,
pubmed-meshheading:1372670-Interleukin-2,
pubmed-meshheading:1372670-Interleukin-4,
pubmed-meshheading:1372670-Interleukin-6,
pubmed-meshheading:1372670-Leukemia, B-Cell,
pubmed-meshheading:1372670-Lymphocyte Activation,
pubmed-meshheading:1372670-Palatine Tonsil,
pubmed-meshheading:1372670-Proteins,
pubmed-meshheading:1372670-Transforming Growth Factor beta,
pubmed-meshheading:1372670-Tumor Necrosis Factor-alpha
|
pubmed:year |
1992
|
pubmed:articleTitle |
Molecular investigation of the cytokines produced by normal and malignant B lymphocytes.
|
pubmed:affiliation |
Dipartimento di Scienze Biomediche e Oncologia Umana, Sezione Clinica, Torino, Italy.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|